The assessment of left ventricular (LV) systolic function and quantification of LV ejection fraction (EF) in patients with atrial fibrillation (AF) can be difficult. We previously demonstrated that LV volume changes over the 100 ms of systole (LVEF100ms) can be used as a measure of LV systolic function. We sought to evaluate the applicability of LVEF100ms in AF patients. We screened AF patients who underwent prospective systolic ECG-triggered cardiac computed tomography (CT) from January 2015 to June 2023. The correlation between LVEF100ms and echocardiography-derived LVEF was assessed. Patients were categorized into three groups based on echocardiographic LVEF (≤40%, 40-55%, ≥55%), and LVEF100ms was compared among these groups. Receiver operating characteristic curve analysis and Cox proportional hazards models were applied to determine the optimal LVEF100ms cut-off for predicting LVEF ≤40% and major adverse cardiovascular events (MACE), defined as a composite of cardiac death, myocardial infarction, heart failure hospitalization, and stroke. Of the total 123 patients, 62 (50.4%) patients had LVEF ≥55%, 40 (32.5%) had LVEF 40-50%, and 21 (17.1%) had LVEF ≤40%. LVEF100ms correlated with echocardiography-derived LVEF (p <0.001) and differed significantly among groups (p <0.001). LVEF100ms ≤3.3% predicted LVEF ≤40% (AUC 0.809, sensitivity 87%, specificity 67%). Patients with LVEF100ms ≤3.3% had higher rate of MACE compared to those without (p = 0.030), and LVEF100ms ≤3.3% was an independent predictor of MACE. LVEF100ms can provide a useful indicator of LV dysfunction in AF patients undergoing prospective ECG-triggered cardiac CT.
Read full abstract